Boston Scientific denied patent infringement appeal:
This article was originally published in Clinica
The US Supreme High Court has rejected Boston Scientific's appeal against a $63.5 million award for patent infringement. The original action was brought by Pfizer subsidiaries Schneider Europe and Schneider USA against Boston's subsidiary SciMed Life Systems for infringement of cardiac catheter patents. The High Court let stand the lower court ruling without comment.